XOMA Launches XOMA 358 Clinical Development By: Benzinga via Benzinga October 09, 2014 at 09:22 AM EDT XOMA Corporation (Nasdaq: XOMA), a leader in the discovery and development of therapeutic antibodies, today announced it has initiated ... Read More >>